Endocrine Disruptors: Focus on the Adrenal Cortex
Hormone and Metabolic Research · 01.01.2024 · 56 (01) · 78-90
DOI: 10.1055/a-2198-9307 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.01.2024. Verfasst von Benedikt Pötzl und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital of Würzburg, Würzburg, Germany. Hauptthemen laut MEDLINE: Adrenal Cortex, Endocrine Disruptors. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Graduate School of Life Sciences, Julius-Maximilians-Universität Würzburg.
Abstract (Originalsprache)
Endocrine-disrupting chemicals (EDCs) are exogenous substances known to interfere with endocrine homeostasis and promote adverse health outcomes. Their impact on the adrenal cortex, corticosteroids and their physiological role in the organism has not yet been sufficiently elucidated. In this review, we collect experimental and epidemiological evidence on adrenal disruption by relevant endocrine disruptors. In vitro data suggest significant alterations of gene expression, cell signalling, steroid production, steroid distribution, and action. Additionally, morphological studies revealed disturbances in tissue organization and development, local inflammation, and zone-specific hyperplasia. Finally, endocrine circuits, such as the hypothalamic-pituitary-adrenal axis, might be affected by EDCs. Many questions regarding the detection of steroidogenesis disruption and the effects of combined toxicity remain unanswered. Not only due to the diverse mode of action of adrenal steroids and their implication in many common diseases, there is no doubt that further research on endocrine disruption of the adrenocortical system is needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital of Würzburg, Würzburg, Germany.
- Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.
- Central Laboratory, Core Unit Clinical Mass Spectrometry, University Hospital of Würzburg, Würzburg, Germany.
Förderung
- Deutsche Forschungsgemeinschaft
- Graduate School of Life Sciences, Julius-Maximilians-Universität Würzburg
Zitieren
APA
Pötzl, B., Kürzinger, L., Stopper, H., Fassnacht, M., Kurlbaum, M., & Dischinger, U. (2024). Endocrine Disruptors: Focus on the Adrenal Cortex. Hormone and Metabolic Research, 56(01), 78-90. https://doi.org/10.1055/a-2198-9307
Vancouver
Pötzl B, Kürzinger L, Stopper H, Fassnacht M, Kurlbaum M, Dischinger U. Endocrine Disruptors: Focus on the Adrenal Cortex. Hormone and Metabolic Research. 2024;56(01):78-90. doi:10.1055/a-2198-9307
BibTeX
@article{Ptzl2024,
author = {Pötzl, Benedikt and Kürzinger, Lydia and Stopper, Helga and Fassnacht, Martin and Kurlbaum, Max and Dischinger, Ulrich},
title = {Endocrine Disruptors: Focus on the Adrenal Cortex},
journal = {Hormone and Metabolic Research},
year = {2024},
volume = {56},
number = {01},
pages = {78--90},
doi = {10.1055/a-2198-9307}
}
EUVIMED